Primary treatment for stage D2 prostate cancer: a randomized study of combined androgen blockade alone versus combined with UFT

Gan to kagaku ryoho. Cancer & chemotherapy

Volumn 26, Issue 8, 1999, Pages 1153-1158

  Sumiyoshi, Y ^a   Hashine, K ^a   Kuwahara, M ^a   Aki, M ^a   Yamamoto, A ^a   Akazawa, S ^a   Takenaka, A ^a  

^a NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; FLUTAMIDE; LEUPRORELIN; TEGAFUR; URACIL;

ADENOCARCINOMA; AGED; ARTICLE; CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; PROSTATE TUMOR; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FLUTAMIDE; HUMANS; LEUPROLIDE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; TEGAFUR; TREATMENT OUTCOME; URACIL;

EID: 0033160695     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)